CD40 and neoplasm: We treated 4662 tumor-bearing mice with a single dose of gemcitabine (G) and/or nab-paclitaxel (A), seven doses anti-PD-1 Ab (P) and/or three doses of anti-CTLA-4 Ab (C) every three days, and one dose of agonistic anti-CD40 Ab (F).